Abramson Cancer Center Clinical Research Unit — Philadelphia, Pennsylvania

Abramson Cancer Center Clinical Research Unit is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 56/100 (POOR). This profile has not yet been claimed by the site owner.

Abramson Cancer Center Clinical Research Unit has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.

Sponsors: Revolution Medicines, Inc..

Sponsor Feasibility Report

Trust Score: 56/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Abramson Cancer Center Clinical Research Unit?

Abramson Cancer Center Clinical Research Unit has a Crixeo Trust Score of 56/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Abramson Cancer Center Clinical Research Unit conducted?

Abramson Cancer Center Clinical Research Unit has 1 clinical trials on record, with 1 currently active. Their work covers Pancreatic Cancer, PDAC, PDAC - Pancreatic Ductal Adenocarcinoma.

Is Abramson Cancer Center Clinical Research Unit accredited by Crixeo Health?

Abramson Cancer Center Clinical Research Unit has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Abramson Cancer Center Clinical Research Unit?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.